RE:RE:RE:RE:RE:BTD Approval Request...???I don't think that we should be worried about the info. not yet disclosed by TLT management. They know what they have, the know where they're heading, they know what they have to do to get there.
It's highly confidential. And given that TLT is quite vulnerable in terms of capital, given the OSC thing of Feb. 2018, better keep things low profile until the perfect moment, so nothing is derailed.
I can understand that some here are "insecured", "frustrated", etc ..., but they don't know what's coming up. And expecting them to know everything is irrealistic. And because there's a lot at stake, I think we have to trust the management. So far, they're brought us to the door of a Breakthrough designation, with what looks like a oncology game-changer, something big pharmas have not been able to do over the last 40 years. So being "insatisfied" about management, when in fact they delivered so far on all fronts (even on the COVID-19, when nobody ever thought of it) except the share price, is a bit special. We all know that when we have enough clear data, the stock price will position itself. So lets focus on the real thing; data. The rest (share price) will follow.